Cargando…

Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study

BACKGROUND: The risk factors for progression of chronic kidney disease (CKD) in type 2 diabetes mellitus (DM) have not been fully elucidated. Although uncontrolled blood pressure (BP) is known to be deleterious, other factors may become more important once BP is treated. METHODS: All patients seen i...

Descripción completa

Detalles Bibliográficos
Autores principales: Leehey, David J, Kramer, Holly J, Daoud, Tarek M, Chatha, Maninder P, Isreb, Majd A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1180831/
https://www.ncbi.nlm.nih.gov/pubmed/15985177
http://dx.doi.org/10.1186/1471-2369-6-8
_version_ 1782124618393321472
author Leehey, David J
Kramer, Holly J
Daoud, Tarek M
Chatha, Maninder P
Isreb, Majd A
author_facet Leehey, David J
Kramer, Holly J
Daoud, Tarek M
Chatha, Maninder P
Isreb, Majd A
author_sort Leehey, David J
collection PubMed
description BACKGROUND: The risk factors for progression of chronic kidney disease (CKD) in type 2 diabetes mellitus (DM) have not been fully elucidated. Although uncontrolled blood pressure (BP) is known to be deleterious, other factors may become more important once BP is treated. METHODS: All patients seen in the outpatient clinics of our hospital between January 1993 and September 2002 with type 2 DM and clinical evidence of CKD were evaluated. Progression of kidney disease was evaluated by rate of decline of glomerular filtration rate (GFR) as estimated from the simplified MDRD formula. Variables associated with progression in univariate analyses were examined by multivariate analysis to determine the factors independently associated with kidney disease progression. RESULTS: 343 patients (mean age 69 years; all male; 77% Caucasian) were studied. Mean BP, glycated hemoglobin, and serum cholesterol during the study period were 138/72 mmHg, 8.1%, and 4.8 mmol/L, respectively. Mean decline of GFR was 4.5 ml min-1 1.73 m(2)-1 yr-1 (range -14 to +32). Low initial serum albumin (p < 0.001), black race (p < 0.001), and degree of proteinuria (p = 0.002), but not blood pressure, glycated hemoglobin, or serum cholesterol, were independently associated with progression. CONCLUSION: In a cohort of diabetic patients with CKD in whom mean BP was < 140/80 mmHg, the potentially remediable factors hypoalbuminemia and proteinuria but not blood pressure were independently associated with progression of kidney disease. Further understanding of the relationship between these factors and kidney disease progression may lead to beneficial therapies in such patients.
format Text
id pubmed-1180831
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11808312005-07-28 Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study Leehey, David J Kramer, Holly J Daoud, Tarek M Chatha, Maninder P Isreb, Majd A BMC Nephrol Research Article BACKGROUND: The risk factors for progression of chronic kidney disease (CKD) in type 2 diabetes mellitus (DM) have not been fully elucidated. Although uncontrolled blood pressure (BP) is known to be deleterious, other factors may become more important once BP is treated. METHODS: All patients seen in the outpatient clinics of our hospital between January 1993 and September 2002 with type 2 DM and clinical evidence of CKD were evaluated. Progression of kidney disease was evaluated by rate of decline of glomerular filtration rate (GFR) as estimated from the simplified MDRD formula. Variables associated with progression in univariate analyses were examined by multivariate analysis to determine the factors independently associated with kidney disease progression. RESULTS: 343 patients (mean age 69 years; all male; 77% Caucasian) were studied. Mean BP, glycated hemoglobin, and serum cholesterol during the study period were 138/72 mmHg, 8.1%, and 4.8 mmol/L, respectively. Mean decline of GFR was 4.5 ml min-1 1.73 m(2)-1 yr-1 (range -14 to +32). Low initial serum albumin (p < 0.001), black race (p < 0.001), and degree of proteinuria (p = 0.002), but not blood pressure, glycated hemoglobin, or serum cholesterol, were independently associated with progression. CONCLUSION: In a cohort of diabetic patients with CKD in whom mean BP was < 140/80 mmHg, the potentially remediable factors hypoalbuminemia and proteinuria but not blood pressure were independently associated with progression of kidney disease. Further understanding of the relationship between these factors and kidney disease progression may lead to beneficial therapies in such patients. BioMed Central 2005-06-28 /pmc/articles/PMC1180831/ /pubmed/15985177 http://dx.doi.org/10.1186/1471-2369-6-8 Text en Copyright © 2005 Leehey et al; licensee BioMed Central Ltd.
spellingShingle Research Article
Leehey, David J
Kramer, Holly J
Daoud, Tarek M
Chatha, Maninder P
Isreb, Majd A
Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study
title Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study
title_full Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study
title_fullStr Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study
title_full_unstemmed Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study
title_short Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study
title_sort progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1180831/
https://www.ncbi.nlm.nih.gov/pubmed/15985177
http://dx.doi.org/10.1186/1471-2369-6-8
work_keys_str_mv AT leeheydavidj progressionofkidneydiseaseintype2diabetesbeyondbloodpressurecontrolanobservationalstudy
AT kramerhollyj progressionofkidneydiseaseintype2diabetesbeyondbloodpressurecontrolanobservationalstudy
AT daoudtarekm progressionofkidneydiseaseintype2diabetesbeyondbloodpressurecontrolanobservationalstudy
AT chathamaninderp progressionofkidneydiseaseintype2diabetesbeyondbloodpressurecontrolanobservationalstudy
AT isrebmajda progressionofkidneydiseaseintype2diabetesbeyondbloodpressurecontrolanobservationalstudy